US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SCILEX HOLDING COMPANY C/WTS 10/11/2027(TO PUR COM)

0.1643

+0.01187.74%

Volume:2.26K

Turnover:344.80

Market Cap:1.14M

PE:0.00

High:0.1653

Open:0.1652

Low:0.1110

Close:0.1525

52wk High:0.6500

52wk Low:0.0375

Shares:6.96M

Float Shares:6.96M

Volume Ratio:3.44

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-33.1842

ROE:--

ROA:-59.70%

PB:-0.01

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

SCILEX HOLDING COMPANY C/WTS 10/11/2027(TO PUR COM)

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.scilexholding.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Scilex Holding Company, a biopharmaceutical company, focuses on acquiring, developing, and commercializing non-opioid management products for the treatment of acute and chronic pain. It offers ZTlido, a prescription lidocaine topical product for the relief of neuropathic pain related with postherpetic neuralgia, which is a form of post-shingles nerve pain. The company also develops SP-102, a viscous gel formulation of corticosteroid for epidural injections that is in a Phase III clinical trial to treat lumbosacral radicular pain; SP-103, which is in Phase II clinical trial for the treatment of low back pain; and SP-104 (4.5 mg), a novel low-dose delayed-release naltrexone hydrochloride formulation that has completed Phase I clinical trial for the treatment of fibromyalgia. The company is headquartered in Palo Alto, California. Scilex Holding Company is a subsidiary of Sorrento Therapeutics, Inc.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SCLXW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SCLXW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCLXW\",,,,,undefined,":{"symbol":"SCLXW","market":"US","secType":"STK","nameCN":"SCILEX HOLDING COMPANY C/WTS 10/11/2027(TO PUR COM)","latestPrice":0.1643,"timestamp":1771621200000,"preClose":0.1525,"halted":0,"volume":2255,"delay":0,"changeRate":0.07737704918032791,"floatShares":6955697,"shares":6955697,"eps":-33.1842,"marketStatus":"Market Closed","change":0.0118,"latestTime":"02-20 16:00:00 EST","open":0.1652,"high":0.1653,"low":0.111,"amount":344.801995,"amplitude":0.356066,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-33.1842,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.1525,"volumeRatio":3.4438003697801647},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCLXW\",,,,,undefined,":{"symbol":"SCLXW","floatShares":6955697,"roa":"-59.70%","roe":"--","lyrEps":0,"volumeRatio":3.4438003697801647,"shares":6955697,"dividePrice":0,"high":0.1653,"amplitude":0.356066,"preClose":0.1525,"low":0.111,"week52Low":0.0375,"pbRate":"-0.01","psRate":"0.02","week52High":0.65,"institutionHeld":0,"latestPrice":0.1643,"eps":-33.1842,"divideRate":0,"volume":2255,"delay":0,"ttmEps":-33.1842,"open":0.1652,"prevYearClose":0.0949,"prevWeekClose":0.1497,"prevMonthClose":0.14,"prevQuarterClose":0.0949,"fiveDayClose":0.1499,"twentyDayClose":0.145,"sixtyDayClose":0.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SCLXW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SCLXW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SCLXW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.scilexholding.com","stockEarnings":[{"period":"1week","weight":0.0975},{"period":"1month","weight":0.3133},{"period":"3month","weight":0.0269},{"period":"6month","weight":-0.6841},{"period":"1year","weight":0.4007},{"period":"ytd","weight":0.7313}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Scilex Holding Company, a biopharmaceutical company, focuses on acquiring, developing, and commercializing non-opioid management products for the treatment of acute and chronic pain. It offers ZTlido, a prescription lidocaine topical product for the relief of neuropathic pain related with postherpetic neuralgia, which is a form of post-shingles nerve pain. The company also develops SP-102, a viscous gel formulation of corticosteroid for epidural injections that is in a Phase III clinical trial to treat lumbosacral radicular pain; SP-103, which is in Phase II clinical trial for the treatment of low back pain; and SP-104 (4.5 mg), a novel low-dose delayed-release naltrexone hydrochloride formulation that has completed Phase I clinical trial for the treatment of fibromyalgia. The company is headquartered in Palo Alto, California. Scilex Holding Company is a subsidiary of Sorrento Therapeutics, Inc.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":1.386497},{"month":2,"riseRate":0.4,"avgChangeRate":-0.105461},{"month":3,"riseRate":0.5,"avgChangeRate":0.000965},{"month":4,"riseRate":0.6,"avgChangeRate":0.094252},{"month":5,"riseRate":0.2,"avgChangeRate":-0.09574},{"month":6,"riseRate":0.6,"avgChangeRate":0.094055},{"month":7,"riseRate":0.8,"avgChangeRate":0.891221},{"month":8,"riseRate":0.2,"avgChangeRate":-0.142129},{"month":9,"riseRate":0.2,"avgChangeRate":-0.220439},{"month":10,"riseRate":0.8,"avgChangeRate":0.142407},{"month":11,"riseRate":0.6,"avgChangeRate":0.046068},{"month":12,"riseRate":0,"avgChangeRate":-0.285719}],"exchange":"NASDAQ","name":"SCILEX HOLDING COMPANY C/WTS 10/11/2027(TO PUR COM)","nameEN":"SCILEX HOLDING COMPANY C/WTS 10/11/2027(TO PUR COM)"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SCLXW\",market:\"US\",,,undefined,":null}}